BioCentury
ARTICLE | Company News

Cancer Research Technology, Varleigh Dx sales and marketing update

January 27, 2017 9:10 PM UTC

Varleigh launched an ELISA assay in the U.K. to aid in the diagnosis of pancreatic cancer. The test, which has CE Mark approval, measures the concentration of antibodies bound to the minichromosome ma...

BCIQ Company Profiles

Cancer Research Technology Ltd.